Charles Schwab’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-115,418
| Closed | -$99.4K | – | 3544 |
|
|
2025
Q1 | $99.4K | Buy |
115,418
+187
| +0.2% | +$161 | ﹤0.01% | 3345 |
|
|
2024
Q4 | $194K | Sell |
115,231
-22,256
| -16% | -$37.4K | ﹤0.01% | 3333 |
|
|
2024
Q3 | $392K | Hold |
137,487
| – | – | ﹤0.01% | 3220 |
|
|
2024
Q2 | $322K | Buy |
137,487
+1,133
| +0.8% | +$2.65K | ﹤0.01% | 3349 |
|
|
2024
Q1 | $401K | Hold |
136,354
| – | – | ﹤0.01% | 3107 |
|
|
2023
Q4 | $408K | Sell |
136,354
-9,124
| -6% | -$27.3K | ﹤0.01% | 3150 |
|
|
2023
Q3 | $460K | Buy |
145,478
+7,662
| +6% | +$24.2K | ﹤0.01% | 3072 |
|
|
2023
Q2 | $533K | Buy |
137,816
+6,213
| +5% | +$24K | ﹤0.01% | 3020 |
|
|
2023
Q1 | $365K | Buy |
131,603
+4,597
| +4% | +$12.7K | ﹤0.01% | 3042 |
|
|
2022
Q4 | $229K | Hold |
127,006
| – | – | ﹤0.01% | 3159 |
|
|
2022
Q3 | $270K | Hold |
127,006
| – | – | ﹤0.01% | 3125 |
|
|
2022
Q2 | $342K | Buy |
127,006
+104,750
| +471% | +$282K | ﹤0.01% | 3171 |
|
|
2022
Q1 | $97K | Hold |
22,256
| – | – | ﹤0.01% | 3419 |
|
|
2021
Q4 | $116K | Hold |
22,256
| – | – | ﹤0.01% | 3421 |
|
|
2021
Q3 | $137K | Buy |
+22,256
| New | +$137K | ﹤0.01% | 3351 |
|